Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.

Inhibiting prolactin reduces hair follicle activation in cashmere goats.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Prolactin slows down hair growth in mice.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Low prolactin in young women may increase heart and metabolism risks.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Certain genes are linked to wool follicle structure and function, but not hair cycle regulation.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Hormones significantly affect hair growth and loss, with potential for new treatments.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

Mirtazapine can cause male breast enlargement.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.